- Home
- DRCT vs HSCS Comparison
DRCT vs HSCS Comparison
Compare DRCT & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRCT
- HSCS
- Stock Information
- Founded
- DRCT 2018
- HSCS 2007
- Country
- DRCT United States
- HSCS United States
- Employees
- DRCT N/A
- HSCS N/A
- Industry
- DRCT Computer Software: Programming Data Processing
- HSCS Medical Specialities
- Sector
- DRCT Technology
- HSCS Health Care
- Exchange
- DRCT Nasdaq
- HSCS Nasdaq
- Market Cap
- DRCT 8.9M
- HSCS 9.9M
- IPO Year
- DRCT 2022
- HSCS 2022
- Fundamental
- Price
- DRCT $0.20
- HSCS $3.01
- Analyst Decision
- DRCT Strong Buy
- HSCS Strong Buy
- Analyst Count
- DRCT 1
- HSCS 2
- Target Price
- DRCT $6.00
- HSCS $10.50
- AVG Volume (30 Days)
- DRCT 5.9M
- HSCS 32.2K
- Earning Date
- DRCT 11-06-2025
- HSCS 12-15-2025
- Dividend Yield
- DRCT N/A
- HSCS N/A
- EPS Growth
- DRCT N/A
- HSCS N/A
- EPS
- DRCT N/A
- HSCS N/A
- Revenue
- DRCT $35,369,000.00
- HSCS $6,250.00
- Revenue This Year
- DRCT $16.81
- HSCS N/A
- Revenue Next Year
- DRCT $35.28
- HSCS N/A
- P/E Ratio
- DRCT N/A
- HSCS N/A
- Revenue Growth
- DRCT N/A
- HSCS N/A
- 52 Week Low
- DRCT $0.19
- HSCS $2.52
- 52 Week High
- DRCT $6.59
- HSCS $6.47
- Technical
- Relative Strength Index (RSI)
- DRCT 32.51
- HSCS 49.07
- Support Level
- DRCT $0.19
- HSCS $2.88
- Resistance Level
- DRCT $0.42
- HSCS $3.29
- Average True Range (ATR)
- DRCT 0.05
- HSCS 0.18
- MACD
- DRCT -0.01
- HSCS 0.03
- Stochastic Oscillator
- DRCT 6.12
- HSCS 72.46
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.